MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation

References

• Kato M, Slack FJ. MicroRNAs: small molecules with big roles - C. elegans to human cancer. Biol Cell 2008; 100:71 - 81; http://dx.doi.org/10.1042/BC20070078; PMID: 18199046
   PubMed Web of Science ®Google Scholar
• Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006; 15:R17 - 29; http://dx.doi.org/10.1093/hmg/ddl046; PMID: 16651366
   PubMed Web of Science ®Google Scholar
• Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki S, Liu Q, et al. ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol 2010; 17:17 - 23; http://dx.doi.org/10.1038/nsmb.1733; PMID: 19966796
   PubMed Web of Science ®Google Scholar
• Ahmed FE. Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev Mol Diagn 2007; 7:569 - 603; http://dx.doi.org/10.1586/14737159.7.5.569; PMID: 17892365
   PubMed Web of Science ®Google Scholar
• Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005; 132:4653 - 62; http://dx.doi.org/10.1242/dev.02073; PMID: 16224045
   PubMed Web of Science ®Google Scholar
• Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011; 91:827 - 87; http://dx.doi.org/10.1152/physrev.00006.2010; PMID: 21742789
   PubMed Web of Science ®Google Scholar
• Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol 2011; 223:102 - 15; http://dx.doi.org/10.1002/path.2806; PMID: 21125669
   PubMed Web of Science ®Google Scholar
• Patel SH, Kooby DA. Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am 2011; 91:1039 - 77; http://dx.doi.org/10.1016/j.suc.2011.06.009; PMID: 21889029
   PubMed Web of Science ®Google Scholar
• Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, et al. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 2010; 29:5761 - 71; http://dx.doi.org/10.1038/onc.2010.352; PMID: 20802530
   PubMed Web of Science ®Google Scholar
• Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 2010; 14:1170 - 9; http://dx.doi.org/10.1007/s11605-010-1202-2; PMID: 20422307
   PubMed Web of Science ®Google Scholar
• Gao CP, Zhang ZY, Cai GH, Liu WZ, Xiao SD, Lu H. Reduced expression of miR-218 and its significance in gastric cancer. Zhonghua Zhong Liu Za Zhi 2010; 32:249 - 52; PMID: 20510072
   PubMedGoogle Scholar
• Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, et al. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res 2011; 17:2725 - 33; http://dx.doi.org/10.1158/1078-0432.CCR-10-2132; PMID: 21220473
   PubMed Web of Science ®Google Scholar
• Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010; 116:41 - 9; PMID: 19890957
   PubMed Web of Science ®Google Scholar
• Li WX. Canonical and non-canonical JAK-STAT signaling. Trends Cell Biol 2008; 18:545 - 51; http://dx.doi.org/10.1016/j.tcb.2008.08.008; PMID: 18848449
   PubMed Web of Science ®Google Scholar
• Ingley E, Klinken SP. Cross-regulation of JAK and Src kinases. Growth Factors 2006; 24:89 - 95; http://dx.doi.org/10.1080/08977190500368031; PMID: 16393697
   PubMed Web of Science ®Google Scholar
• Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol 2007; 178:2623 - 9; PMID: 17312100
   PubMed Web of Science ®Google Scholar
• Yu LF, Zhu YB, Qiao MM, Zhong J, Tu SP, Wu YL. Constitutive activation and clinical significance of Stat3 in human gastric cancer tissues and cell lines. Zhonghua Yi Xue Za Zhi 2004; 84:2064 - 9; PMID: 15730617
   PubMedGoogle Scholar
• Vera J, Rateitschak K, Lange F, Kossow C, Wolkenhauer O, Jaster R. Systems biology of JAK-STAT signalling in human malignancies. Prog Biophys Mol Biol 2011; 106:426 - 434; http://dx.doi.org/10.1016/j.pbiomolbio.2011.06.013; PMID: 21762720
   PubMed Web of Science ®Google Scholar
• Constantinescu SN, Girardot M, Pecquet C. Mining for JAK-STAT mutations in cancer. Trends Biochem Sci 2008; 33:122 - 31; http://dx.doi.org/10.1016/j.tibs.2007.12.002; PMID: 18291658
   PubMed Web of Science ®Google Scholar
• Valentino L, Pierre J. JAK/STAT signal transduction: regulators and implication in hematological malignancies. Biochem Pharmacol 2006; 71:713 - 21; http://dx.doi.org/10.1016/j.bcp.2005.12.017; PMID: 16426581
   PubMed Web of Science ®Google Scholar
• Benes V, Castoldi M. Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available. Methods 2010; 50:244 - 9; http://dx.doi.org/10.1016/j.ymeth.2010.01.026; PMID: 20109550
   PubMed Web of Science ®Google Scholar
• Witkos TM, Koscianska E, Krzyzosiak WJ. Practical aspects of microRNA target prediction. Curr Mol Med 2011; 11:93 - 109; http://dx.doi.org/10.2174/156652411794859250; PMID: 21342132
   PubMed Web of Science ®Google Scholar
• Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet 2009; 374:477 - 90; http://dx.doi.org/10.1016/S0140-6736(09)60617-6; PMID: 19625077
   PubMed Web of Science ®Google Scholar
• Rathbone M, Rathbone B. Helicobacter pylori and Gastric Cancer. Recent Results Cancer Res 2011; 185:83 - 97; http://dx.doi.org/10.1007/978-3-642-03503-6_5; PMID: 21822821
   PubMedGoogle Scholar
• Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg 2011; 396:729 - 42; http://dx.doi.org/10.1007/s00423-011-0810-y; PMID: 21611816
   PubMed Web of Science ®Google Scholar
• Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010; 11:136 - 46; http://dx.doi.org/10.1016/S1470-2045(09)70343-2; PMID: 20022810
   PubMed Web of Science ®Google Scholar
• Navarro A, Diaz T, Martinez A, Gaya A, Pons A, Gel B, et al. Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood 2009; 114:2945 - 51; http://dx.doi.org/10.1182/blood-2009-02-204842; PMID: 19666866
   PubMed Web of Science ®Google Scholar
• Liu S, Guo W, Shi J, Li N, Yu X, Xue J, et al.. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 2011; In press http://dx.doi.org/10.1016/j.jhep.2011.08.008; PMID: 21888875
   PubMed Web of Science ®Google Scholar
• Smirnova OV, Ostroukhova TY, Bogorad RL. JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?. World J Gastroenterol 2007; 13:6478 - 91; http://dx.doi.org/10.3748/wjg.13.6478; PMID: 18161917
   PubMed Web of Science ®Google Scholar
• Santos FP, Verstovsek S. JAK2 inhibitors: what's the true therapeutic potential?. Blood Rev 2011; 25:53 - 63; http://dx.doi.org/10.1016/j.blre.2010.10.004; PMID: 21095048
   PubMed Web of Science ®Google Scholar
• Quintás-Cardama A, Verstovsek S. New JAK2 inhibitors for myeloproliferative neoplasms. Expert Opin Investig Drugs 2011; 20:961 - 72; http://dx.doi.org/10.1517/13543784.2011.579560; PMID: 21521147
   PubMed Web of Science ®Google Scholar